Lebenthal Global Advisors, LLC Bristol Myers Squibb CO Transaction History

Lebenthal Global Advisors, LLC

$540 Million
Q4 2024

A detailed history of Lebenthal Global Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 13,677 shares of BMY stock, worth $763,586. This represents 0.14% of its overall portfolio holdings.

Number of Shares

13,677

Previous 13,323 2.66%

Holding current value

$763,586

Previous $689,000 12.19%

% of portfolio

0.14%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$51.92 - $59.94 $18,379 - $21,218	354 Added 2.66%	13,677 $773,000
Q3 2024 Oct 28, 2024	BUY	$39.66 - $51.75 $86,379 - $112,711	2,178 Added 19.54%	13,323 $689,000
Q2 2024 Jul 24, 2024	BUY	$40.25 - $52.99 $1,489 - $1,960	37 Added 0.33%	11,145 $462,000
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $10,459 - $11,859	218 Added 2.0%	11,108 $602,000
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $83,094 - $99,154	1,714 Added 18.68%	10,890 $558,000
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $42,375 - $47,382	-732 Reduced 7.39%	9,176 $532,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $39,818 - $44,212	-625 Reduced 5.93%	9,908 $633,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $10,250 - $11,626	156 Added 1.5%	10,533 $730,000
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $143,534 - $169,964	2,096 Added 25.31%	10,377 $746,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $61 - $36,268	472 Added 6.04%	8,281 $588,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $567,089 - $624,563	7,809 New	7,809 $601,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $500,201 - $599,785	-8,136 Closed	0 $0
Q4 2021 Apr 15, 2022	SELL	$53.63 - $62.52 $73,312 - $85,464	-1,367 Reduced 14.38%	8,136 $507,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $509,645 - $594,127	9,503 New	9,503 $592,000
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $896,425 - $1.05 Million	-15,150 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $937,936 - $1.02 Million	15,150 New	15,150 $1.01 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $308,271 - $346,714	-5,195 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $299,959 - $339,908	5,195 New	5,195 $322,000

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.

Account

Lebenthal Global Advisors, LLC Bristol Myers Squibb CO Transaction History